ParasitologyEvaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples
Introduction
Enteric protozoa continue to be the most commonly encountered parasitic diseases affecting millions of people each year and causing significant morbidity and mortality worldwide (Stark et al., 2009). Pathogenic enteric parasites include Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis. While Blastocystis is the most common enteric parasite detected in humans, it remains a controversial cause of gastrointestinal disease (Roberts et al., 2013).
Traditional diagnostic methods for the detection of enteric protozoa rely on either microscopic examination of faecal material or enzyme immunoassays (Garcia et al., 2000). More recently numerous PCR assays have been described in the literature (Liang et al., 2010, Stark et al., 2006, Stark et al., 2011). These PCR assays have the advantage of greater sensitivity and the capacity for multiple parasite detection in the form of multiplexed reactions (Liu et al., 2013, Nazeer et al., 2013).
The EasyScreen™ Enteric Parasite Detection Kit (Genetic Signatures, Sydney, Australia) is a simple and rapid molecular method that utilises 3base™ technology that modifies the 4 usual DNA base pairs (A, C, T, G) into only 3 base pairs (A, T, G) via a novel, patented bisulphite conversion step. The EasyScreen™ kit comprises of an extraction kit/protocol and an real time PCR (RT-PCR) amplification kit containing all the primers and probes to detect the following targets: Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis. It also contains an extraction and separate amplification control for the detection of PCR inhibition. The kit can be run on various platforms and has the option to be semi-automated.
This is the first study to evaluate the EasyScreen™ Enteric Parasite Detection Kit for the simultaneous detection and identification of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis in human clinical samples.
Section snippets
Faecal specimens
Faecal specimens submitted to the Department of Microbiology at St. Vincent's Hospital, Sydney, for investigation of diarrhoea from September 2011 to December 2012 were included in the study. A total of 358 samples were included in the study; 108 samples were positive by microscopy for the following parasites: Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis samples. Along with 200 faecal samples tested previously by microscopy using the
Results
The results are summarised in Table 1. A true test-positive result was defined as a sample that was test-positive using at least 2 of the 3 methods employed; any discordant results were repeated. A total of 53 Blastocystis, 43 D. fragilis, 26 G. intestinalis, 24 Entamoeba complex (comprising of the morphologically identical E. histolytica, E. dispar, and E. moshkovskii) and 9 Cryptosporidium spp. were detected by various methods. When compared with microscopy, the molecular methods demonstrated
Discussion
E. histolytica, G. intestinalis, Cryptosporidium, Blastocystis, and D. fragilis are 5 important and commonly occurring parasitic protozoa that infect humans. The EasyScreen™ assay provides an additional diagnostic tool for the rapid, sensitive, and specific detection of these enteric protozoa.
The EasyScreen™ assay uses a novel chemistry that universally modifies the nucleic acid genomes of pathogens by converting all cytosine bases to thymine bases (via a uracil intermediary). This modification
Acknowledgments
This work was supported by a grant from the Institute of Laboratory Science at St. Vincent's Hospital, Sydney, Australia.
References (23)
- et al.
Rapid identification of Giardia duodenalis assemblages in NSW using terminal-restriction fragment length polymorphism
Parasitology
(2012) - et al.
Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections
J Clin Virol
(2008) - et al.
PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia
J Clin Microbiol
(2007) - et al.
Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay
J Clin Microbiol
(2000) - et al.
Evaluation of a new single-tube multiprobe real-time PCR for diagnosis of Entamoeba histolytica and Entamoeba dispar
J Parasitol
(2010) - et al.
A laboratory-developed TaqMan Array Card for simultaneous detection of 19 enteropathogens
J Clin Microbiol
(2013) - et al.
Systematic application of multiplex PCR enhances the detection of bacteria, parasites, and viruses in stool samples
J Infect
(2013) - et al.
Use of multiplex real-time PCR for detection of common diarrhea causing protozoan parasites in Egypt
Parasitol Res
(2013) - et al.
Identification of zoonotic Cryptosporidium and Giardia genotypes infecting animals in Sydney's water catchments
Exp Parasitol
(2011) - et al.
Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of Blastocystis sp. in clinical stool samples
Am J Trop Med Hyg
(2011)
Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis
Eur J Clin Microbiol Infect Dis
Cited by (44)
Comprehensive review of conventional and state-of-the-art detection methods of Cryptosporidium
2022, Journal of Hazardous MaterialsCryptosporidium spp. diagnosis and research in the 21<sup>st</sup> century
2021, Food and Waterborne ParasitologyDiagnóstico molecular de parasitosis intestinales
2020, Enfermedades Infecciosas y Microbiologia ClinicaRapid diagnosis of parasitic diseases: current scenario and future needs
2019, Clinical Microbiology and Infection